Child Health  |  Asthma Pathway - Summary of Stepwise Pharmacological Management in Children Aged 1-4 Years




Child Health

Asthma Pathway - Summary of Stepwise Pharmacological Management in Children Aged 1-4 Years

 

STEP 1: Mild Asthma

Inhaled short acting β2 agonist as required via spacer

undefined

STEP 2: Regular Preventer Therapy

Add inhaled steroid 100-200mcg/twice daily Beclomethasone or Budesonide, or 50 -  100mcg/twice daily Fluticasone

– use the higher dose with greater severity 

undefined

STEP 3: Persistent Poor Control

Refer to paediatrician for review of diagnoses and consideration of LABA’s and/or Montelukast

 

1. LABA’s are not licensed for use <4years (Salmeterol) and <6years (eformoterol), but are an alternative for families who can’t afford to pay for montelukast.

  • The use of licensed medicines for unlicensed indications is often necessary in paediatric practice when there is no suitable alternative.
  • This should be in consultation with a paediatrician
  • For Medicine Data Sheets and further information on the use of Unapproved Medicines consult Medsafe: http://www.medsafe.govt.nz
  • Always need to take corticosteroid with LABA

 



Last updated : Thursday, May 18, 2017
Next review date : Friday, May 18,2018


Disclaimer: This site is intended to be flexible and frequently updated. While every effort has been made to ensure accuracy, all information should be verified.